Skip to content

Aemetis, Inc. AMTX India Biodiesel — D&A

Other segment segments

California Ethanol
$1.06M-4.1%

Similar metrics at other companies

Marathon Petroleum logo
MPCRenewable Diesel — D&A
$16M-11.1%
Quad Graphics logo
QUADInternational — D&A
$1.4M0.0%
MSA
MSAInternational — D&A
$5.97M+32.6%
VAN
VANIBiopharm Division — D&A
$130K+31.3%
Kewaunee Scientific Corporation logo
KEQUInternational — D&A
$88K-16.2%
National Health Investors logo
NHIInvestments — D&A
$16.56M+1.1%

Other financials

Income statement

See full
Revenue$54.6M+27.4%
Gross profit$2.8M+154%
Operating income-$6.3M+59.3%
Net income-$21.7M+11.5%
EPS (diluted)-$0.33+29.8%

Balance sheet

See full
Cash & equivalents$4.8M+861%
Total debt$101.8M+18.6%
Total equity-$321.1M-14.4%
Total assets$270.3M+4.0%

Cash flow

See full
Operating cash flow-$10.6M-6,698%
CapEx$6.5M+259%
Free cash flow-$17.1M-927%

Valuation

See full
Market cap$116.1M-12.6%
Enterprise value$213.07M-0.6%
P/S0.6×0.0×

Profitability

See full
Gross margin-1.6%-0.3pp
Operating margin-13.4%-3.2pp
Net margin-35.4%-1.4pp
FCF margin-18.2%+1.1pp

Returns & leverage

See full
Return on equity24.7%
Debt / equity-0.3×
Current ratio0.1×-0.1×

Where this comes from

Reported directly by Aemetis, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.

The official record: Aemetis, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aemetis, Inc.'s india biodiesel — d&a.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aemetis, Inc.'s india biodiesel — D&A?
Aemetis, Inc. (AMTX) reported india biodiesel — D&A of $189K in Q1 2026.
How has Aemetis, Inc.'s india biodiesel — D&A changed year-over-year?
Aemetis, Inc.'s india biodiesel — D&A increased by 3.3% year-over-year, from $183K to $189K.
What does india biodiesel — D&A mean?
Represents the non-cash allocation of the cost of tangible and intangible assets over their useful lives within the India segment. This metric is essential for understanding the capital intensity and the ongoing reinvestment requirements of the biorefining facilities.